Clinical Consequences of Activating Germline Mutations of TSH Receptor, the Concept of Toxic Hyperplasia

Hormone Research in Paediatrics

Volumn 47, Issue 4-6, 1997, Pages 158-162

  Leclere J ^a   Bene M C ^b   Aubert, V ^a   Klein, M ^a   Pascal Vigneron, V ^a   Weryha, G ^a   Faure, G ^b  

^a CHU NANCY BRABOIS   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Activating mutation; Familial thyrotoxicosis; Nonautoimmune thyrotoxicosis; Toxic hyperplasia; TSH r

Indexed keywords

THYROTROPIN RECEPTOR;

CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; EYE DISEASE; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GERM LINE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNITY; MALE; ONSET AGE; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; SEX RATIO; THYROTOXICOSIS;

ANIMALS; GRAVES DISEASE; HUMANS; HYPERPLASIA; MUTATION; PEDIGREE; RECEPTORS, THYROTROPIN; THYROID GLAND; THYROTOXICOSIS;

EID: 1842295776     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185459     Document Type: Article

References (15)

1. Parma J, Duprcz L, Van Sande J, Cochaux P, Gervy C, Mockcl J, Dumont JE, Vassart G: Somatic mutation in the thyrotropin receptor gene causes hyperfunctioning thyroid adenomas, Nature 1993;365:649-651.
2. Ledere J, Thomas JL: Les hyperthyroidies diffuses non autoimmunes, Ann Endocrinol (Paris) 1982;43:553-568.
3. Thomas JL, Leclerc J, Hartemann P, Duheille J, Orgiazzi J, Petersen M, Janot C, Guedenet JC: Familial hyperthyroidism without evidence of autoimmunity, Acta Endocrinol (Co-penh.) 1982;100:512-518.
4. Duprez L, Parma J, Van Sande J, Allgcier A, Leclerc J, Schvartz C, Delisle MJ, Dccoulx M, Orgiazzi J, Dumont J, Vassart G: Germline mutations in the thyrotropin receptor gene cause non-autosomal dominant hyperthyroidism, Nature Genet 1994;7:396-401.
5. Tonacchera M, Van Sande J, Cctani F, Swillens S, Schvartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G, Parma J: Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia, J Clin Endocrinol Metab 1996;81:547-554.
6. Hollingsworth DR, Mabry C: Congenital Graves’ disease, Am J Dis Child 1976:130: 148-155.
7. Horton GL, Scazziga BR: Hereditary hyperthyroidism with diffuse non autoimmune hyperactivity due to autonomy of function and growth (abstract), Ann Endocrinol (Paris) 1987:48:92.
8. Lindsay S, Chaikof TIL: The effects of irradiation on the thyroid gland with particular reference to the induction of thyroid neoplasms, Cancer Res 1964;24:1099-1103.
9. Williams ED: Mechanisms and pathogenesis of thyroid cancer in animals and man, Mutat Res 1995;333:123-129.
10. Miller JM: Hyperthyroidism from the thyroid follicle with autonomous function, Clin Endocrinol Metab 1978;7:177-197.
11. Bene MC, Derennes V, Faure G, Thomas JL, Duheille J, Leclerc J: Graves' disease: In situ localization of lymphoid T cell subpopulation, Clin Exp Immunol 1983;52:311-316.
12. Bottazzo GF, Pujol-Borrell Hanafusa T, Feld-mann M: Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity, Lancet 1983;2:1115-1118.
13. Leclere J, Bene MC, Duprcz A, Faure G, Thomas JL, Vignaud M, Burlet C: Behaviour of thyroid tissue from patients with Graves' disease in nude mice, J Clin Endocrinol Metab 1984:59:175-177.
14. Dunhill MS: Quantitative methods in histology; in Dyke SC (ed): Recent Advances in Clinical Pathology, London, Churchill Livingstone, 1968, series V, pp 401 -416.
15. Kopp P, Van Sande J, Parma J, Duprcz L, Gerber H, Joss E, Jameson JL, Dumont JE, Vassart G: Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene, N Engl J Med 1995:332:150-154.